ClinicalTrials.Veeva

Menu

The Impact of Antibiotic Prophylaxis on Incidence of Post-bronchoscopy Fever and Change of Serum Cytokines

Seoul National University logo

Seoul National University

Status and phase

Completed
Phase 4

Conditions

Fever
Pneumonia

Treatments

Drug: oral amoxicillin/clavulanate 1g (875/125mg)
Drug: control

Study type

Interventional

Funder types

Other

Identifiers

NCT01089218
postFB fever

Details and patient eligibility

About

Fever can develop after fiberoptic bronchoscopy (FB) in about 2.5 - 16 % of adult patients. We evaluated the impact of oral amoxicillin/clavulanate (AC) on incidence of postbronchoscopic fever and pneumonia.

Full description

For the population being undergone with bronchoscopy, the clinical signs and procedural measures for complication of bronchoscopy and cytokines will be checked.

Enrollment

241 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • adult patients (aged 18 years or older) who underwent FB

Exclusion criteria

  • concurrent treatment with antibiotics or systemic corticosteroid

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

241 participants in 2 patient groups

control
No Intervention group
Description:
control without intervention
Treatment:
Drug: control
Amoxicillin/clavulanate
Active Comparator group
Treatment:
Drug: oral amoxicillin/clavulanate 1g (875/125mg)

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems